Pfizer’s Comirnaty COVID-19 vaccine has been provisionally approved by the Therapeutic Goods Administration (TGA) for use as a booster in those aged 16–17 years.

Compounding environments must be designed to minimise contamination risk —  including keeping meal breaks well away from the bench.

In a move aimed at reducing antibiotic resistance, the Pharmaceutical Benefits Advisory Committee (PBAC) has recommended that four of the most widely prescribed antibiotics...

Almost 1.45 million Australians have some form of chronic obstructive pulmonary disease (COPD). This equates to one in seven Australians over 40 suffering from...

The heart failure medicine has showed some promise in treating alcohol use disorder, through a different mechanism than existing treatments.

A novel therapy under investigation could see pharmacists playing a greater role in helping patients to manage some common eye conditions.